Skip to main content
Caplight Logo









Enantis

Enantis

Private
BrnoHealthcare & Life Scienceshttps://www.enantis.com/

Last Round

Grant

Jul 1, 2024

Total Funding Raised

$3.26M

Company Overview

Enantis is a biotechnology company that develops and manufactures thermostable proteins and provides protein engineering services for therapeutic, cosmetic, and cultured meat applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Fashion & Beauty

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

protein engineeringfibroblast growth factorsFGFrecombinant proteinscomputational protein designthermostable proteinsprotein design softwarecultured meatlab-grown meatenzyme engineeringcontract researchbioinformaticscell culture reagentssynthetic biologysynbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enantis Comparables

Compare Enantis with similar companies based on industry and business-model similarity.

Enantis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ORF Genetics
81%
Core Biogenesis
79%
Levprot Bioscience
78%

Enantis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2024
GrantApr 18, 2024
GrantJan 1, 2020
VC RoundDec 31, 2019
GrantJun 1, 2016
Grant
Sep 1, 2015

Key People

Founding team and executive leadership

Zbynek Prokop

Founder and CEO 2006-2013

Founding Team

Milada Sára Poledňáková

Chief Operating Officer (COO), Project and Office Manager Head of Administration

Executive Team

Enantis Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Monthly visitors grew 82% MoM.

  • Feb 21, 2026

    Grew 42% QoQ from 19 to 27 employees.

Enantis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enantis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enantis's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrno
Employee Range27
Year Founded2006
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?